2018
DOI: 10.31688/abmu.2018.53.3.17
|View full text |Cite
|
Sign up to set email alerts
|

Hepatopulmonary syndrome: proposed mediators of pulmonary vasodilation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 35 publications
(45 reference statements)
0
1
0
Order By: Relevance
“…The pathogenesis of HPS has not been clarified, but since the basis of HPS pathogenesis is the dilation of inner lung capillaries, researchers suggest that HPS is caused by the prolonged action of biologically active compounds on the blood vessels of pulmonary circuit. Possible role in resistant vasodilation has been suggested for many substances synthesized in the body (nitrogen (II) oxide, endothelin B and endothelin-1, prostaglandins E1 and I2, tumor necrosis factor-, vasoactive intestinal polypeptide, substance P, calcitonin, glucagon, platelets activating factor, and others) 9 .…”
Section: Introductionmentioning
confidence: 99%
“…The pathogenesis of HPS has not been clarified, but since the basis of HPS pathogenesis is the dilation of inner lung capillaries, researchers suggest that HPS is caused by the prolonged action of biologically active compounds on the blood vessels of pulmonary circuit. Possible role in resistant vasodilation has been suggested for many substances synthesized in the body (nitrogen (II) oxide, endothelin B and endothelin-1, prostaglandins E1 and I2, tumor necrosis factor-, vasoactive intestinal polypeptide, substance P, calcitonin, glucagon, platelets activating factor, and others) 9 .…”
Section: Introductionmentioning
confidence: 99%